Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Frequently asked questions
What sector does Jiangsu Hengrui Medicine Co Ltd (600276) operate in?
Jiangsu Hengrui Medicine Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Jiangsu Hengrui Medicine Co Ltd (600276) current stock price?
As of the latest data, Jiangsu Hengrui Medicine Co Ltd stock price is CN¥46.76, with a previous close of CN¥47.74. Jiangsu Hengrui Medicine Co Ltd lost -CN¥0.98 in the last trading session, representing a -2.05% loss.
What is Jiangsu Hengrui Medicine Co Ltd (600276) current market capitalization?
Jiangsu Hengrui Medicine Co Ltd market cap is approximately 298.28 billion.
What is Jiangsu Hengrui Medicine Co Ltd (600276) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.16, and the forward EPS is CN¥1.71.
What is Jiangsu Hengrui Medicine Co Ltd (600276) Price-to-Earnings (P/E) ratio?
Jiangsu Hengrui Medicine Co Ltd current P/E ratio is 40.31, with a forward P/E of 27.28.
Does Jiangsu Hengrui Medicine Co Ltd (600276) pay dividends?
No. Jiangsu Hengrui Medicine Co Ltd does not pay a dividend.
How did Jiangsu Hengrui Medicine Co Ltd (600276) perform in its most recent earnings report?
In the last report (June 30, 2026), Jiangsu Hengrui Medicine Co Ltd posted an EPS surprise of 3.03% and a revenue surprise of -7.57%.
What is Jiangsu Hengrui Medicine Co Ltd (600276) beta (volatility) score?
Jiangsu Hengrui Medicine Co Ltd has a beta of 0.041, indicating lower volatility than the overall market.
